Innate Pharma SA
OTC:IPHYF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Innate Pharma SA
OTC:IPHYF
|
FR |
|
Cricut Inc
F:398
|
US |
|
R
|
RBC Bearings Inc
F:B1X
|
US |
|
Innate Pharma SA
NASDAQ:IPHA
|
FR |
|
B
|
Bravura Solutions Ltd
F:BRA
|
AU |
|
Made Tech Group PLC
F:5UH
|
UK |
|
Kofola CeskoSlovensko as
F:48K
|
CZ |
|
A
|
AT & S Austria Technologie & Systemtechnik AG
XMUN:AUS
|
AT |
|
British Land Company PLC
F:BLDA
|
UK |
|
Alphawave IP Group PLC
F:7GL
|
UK |
|
Trend Micro Inc
F:TMI
|
JP |
|
S
|
Sahakol Equipment PCL
SET:SQ
|
TH |
|
Xtract One Technologies Inc.
OTC:XTRAF
|
CA |
|
AT & S Austria Technologie & Systemtechnik AG
F:AUS
|
AT |
Shareholder Yield
Current shareholder yield for 
IPHYF is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
IPHYF Price
Innate Pharma SA
| Average Annual Return | -2.07% |
| Standard Deviation of Annual Returns | 22.63% |
| Max Drawdown | -84% |
| Market Capitalization | 148.8m USD |
| Shares Outstanding | 80 950 800 |
| Percentage of Shares Shorted |
N/A
|
